Phase 3 Trial in the Works for Novel Non-Amyloid Alzheimer’s Drug – BioSpace

July 18, 2019 by  
Filed under Alzheimers News

Sponsored By

Phase 3 Trial in the Works for Novel Non-Amyloid Alzheimer’s Drug  BioSpace

With the latest major Phase 3 failure of Biogen and Eisai’s beta-amyloid-targeting antibody drug aducanumab, researchers are increasingly turning to other drug …

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*